Age, Biography and Wiki
Susan M. Gasser was born on 1955 in Switzerland. Discover Susan M. Gasser's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is She in this year and how She spends money? Also learn how She earned most of networth at the age of 68 years old?
We recommend you to check the complete list of Famous People born on 1955.
She is a member of famous with the age 68 years old group.
Susan M. Gasser Height, Weight & Measurements
At 68 years old, Susan M. Gasser height not available right now. We will update Susan M. Gasser's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
Physical Status |
Height |
Not Available |
Weight |
Not Available |
Body Measurements |
Not Available |
Eye Color |
Not Available |
Hair Color |
Not Available |
Dating & Relationship status
She is currently single. She is not dating anyone. We don't have much information about She's past relationship and any previous engaged. According to our Database, She has no children.
Family |
Parents |
Not Available |
Husband |
Not Available |
Sibling |
Not Available |
Children |
Not Available |
Susan M. Gasser Net Worth
Her net worth has been growing significantly in 2022-2023. So, how much is Susan M. Gasser worth at the age of 68 years old? Susan M. Gasser’s income source is mostly from being a successful . She is from Switzerland. We have estimated
Susan M. Gasser's net worth
, money, salary, income, and assets.
Net Worth in 2023 |
$1 Million - $5 Million |
Salary in 2023 |
Under Review |
Net Worth in 2022 |
Pending |
Salary in 2022 |
Under Review |
House |
Not Available |
Cars |
Not Available |
Source of Income |
|
Susan M. Gasser Social Network
Instagram |
|
Linkedin |
|
Twitter |
|
Facebook |
|
Wikipedia |
|
Imdb |
|
Timeline
Gasser led a research group at the Swiss Institute for Experimental Cancer Research in Epalinges sur Lausanne until 2001, where she coupled biochemical studies with the live imaging of telomeres and repressed chromatin in budding yeast. She was professor of Molecular Biology at the University of Geneva prior to moving in 2004 to be Director of the Friedrich Miescher Institute for Biomedical Research in Basel. At the FMI she also led a research group studying the spatial organization of double-strand break repair and checkpoint activation in yeast, as well as heterochromatin establishment in C. elegans. From 2005 - 2021 she was full professor at the University of Basel, and since February 2021, she is the Director of the ISREC Foundation, which established the new Agora institute of translational cancer research in 2018. Susan Gasser also holds the position of Guest professor at the University of Lausanne. Initially studying long range chromatin organization in budding yeast, her laboratory combined genetic, biochemical and fluorescence microscopy approaches, developing quantitative live imaging tools to study the subnuclear dynamics of DNA loci in living cells. Her work elucidated roles of histone modifications and turnover in genome stability and in the spatial organization of chromatin in the interphase nucleus, with an emphasis on the function of subnuclear compartments in C. elegans development and tissue differentiation. Gasser has served on review boards and advisory councils throughout Switzerland, Europe. and Japan, and is currently Chair of the Strategic Advisory Board of the Helmholtz Society Health Program of Germany. She serves on the ETH Board (Rat der Eidgenossosichen Technischen Hochschulen) and the Swiss Science Council. She served on the Gairdner Foundation Medical Prize committee, the EMBL Science Advisory Council (SAC), and on numerous Foundation boards in Switzerland. She was vice chairperson and then Chairperson of the EMBO Council (2000-2004) and a member of the President's Science and Technology Advisory Council (PSTAC; 2012-2014) for the European Commission. Susan led the Gender Committee of the Swiss National Science Foundation from 2014- 2019, and initiated the PRIMA program for the promotion of women in academia, actively promoting the careers of women scientists in Switzerland, and in Japan, with the establishment of Women in Science Japan. Susan Gasser was elected to the National Academy of Science (US), the Académie de France, Leopoldina, EMBO, AAAS, as well as the Swiss Academy of Medical Sciences, and received the INSERM International Prize in 2011, the FEBS | EMBO Women in Science Award in 2012, the Weizmann Institute Women in Science award, the Otto Naegeli prize in medical research (2006). She holds honorary doctorates from the University of Lausanne, the University of Fribourg, and the Charles University in Prague. In Switzerland she was also recipient of the Friedrich Miescher Award and the National Latsis Prize.
Susan Gasser received her doctorate from the University of Basel in Biochemistry in 1982 having developed an in vitro system for the import of mitochondrial proteins with Gottfried (Jeff) Schatz at the Biozentrum of the University of Basel, after a BA at the University of Chicago with a Honors thesis in Biophysics (1979). As a post-doctoral fellow at the University of Geneva with Ulrich K. Laemmli, she established roles for topoisomerase II in metaphase chromosome structure (Gasser et al., JMB 1986) and for A/T-rich sequences in long-range chromatin folding (Gasser and Laemmli, Cell 1986). She established her own laboratory at the ISREC Swiss Institute for Experimental Cancer Research in Epalinges in 1986.
Susan M. Gasser (born 1955) is a Swiss molecular biologist. She was the Director of the Friedrich Miescher Institute for Biomedical Research in Basel, Switzerland, from 2004 - 2019, where she also led a research group from 2004 until 2021. She was in parallel Professor of molecular biology at the University of Basel until April 2021. Since January 2021, Susan Gasser is Director of the ISREC Foundation, based in Lausanne, and is Professor invité at the University of Lausanne in the Department of Fundamental Microbiology. She is an expert in quantitative biology and studies epigenetic inheritance and genome stability.